Results of elective repair at 6 months or younger in 277 patients with tetralogy of Fallot: A 14-year experience at a single center  by Kirsch, Roxanne E. et al.
Kirsch et al Congenital Heart DiseaseResults of elective repair at 6 months or younger in 277 patients with
tetralogy of Fallot: A 14-year experience at a single centerRoxanne E. Kirsch, MD,a Andrew C. Glatz, MD, MSCE,b J. William Gaynor, MD,c
Susan C. Nicolson, MD,a Thomas L. Spray, MD,c Gil Wernovsky, MD,a,b and Geoffrey L. Bird, MDa,bFrom th
Medi
Cardi
Child
Funding
suppo
Disclos
Receive
publi
Address
324 S
(E-m
0022-52
Copyrig
http://dx
C
H
DObjective: To report practice and outcomes in infants undergoing elective repair of tetralogy of Fallot.
Methods:A review of a retrospective cohort of elective complete repair of infants age 6 months or younger from
1995 to 2009 was performed. Patients were excluded because of previous interventions, hypercyanotic episodes,
intensive care admissions, additional major cardiac defects, or if they were not discharged after birth. Length of
stay, mortality, and complications were recorded. Association was determined using logistic or linear regression
models and univariate testing determined the multivariate model.
Results: There were 277 patients included. The hospital mortality rate was zero. A total of 87.4% of patients
were discharged homewithin 7 days of repair, and 21.6% of patients were discharged on or before the third post-
operative day. The postoperative course was uncomplicated in 245 patients (88.4%). Longer support time was
associated independently with increased odds of complications (P<.001). Longer support time, younger age,
chromosomal abnormality, and presence of a complication were associated independently with a longer hospital
stay (all P<.001). Patients younger than 3 months (n ¼ 110) had a longer median hospital stay (4 vs 3 days;
P<.001) and longer support times (77.3  35.1 min vs 66.4  34 min; P<.01).
Conclusions: Elective tetralogy of Fallot repair was performed at 6 months or younger with low morbidity, no
hospital mortality, and an 11.6% complication rate. Longer support times, lower weight, chromosomal abnor-
malities, and complications were associated with a significantly increased duration of hospital stay. (J Thorac
Cardiovasc Surg 2014;147:713-7)Surgical intervention for tetralogy of Fallot (TOF) during in-
fancy has become routine in many centers since the first
successful ‘‘correction’’ byLillehei et al1more than 50 years
ago,2,3 and acceptable outcomes into young adulthood have
been described.4-8 Most centers in the world have, by
consensus, planned elective repair early in life in patients
with TOF, however, the optimal timing of elective surgical
intervention continues to be controversial.6,9-13
The literature includes reports of theoretical long-term
advantages of primary repair at younger ages,4,6,9,14 and
experience with repair in early infancy.6,15-20 In contrast to
extensive literature reporting good results with repair in
symptomatic infants,7-9,11,12,21-23 there are relatively
limited data concerning the elective repair of infants with
TOF.15 Centers reporting good results note an increased
length of stay (LOS) and increased morbidity in patientse Division of Critical Care,a Department of Anesthesiology and Critical Care
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The Journal of Thoracic and Cayounger than 3 months.4,6,19,20,23,24 Given the differences
in preoperative symptoms and underlying physiology,
extrapolating results of symptomatic patients may not best
inform a course of action for the elective patient.
The purpose of our study was to report surgical practice
and perioperative outcomes of a large cohort of infants
undergoing elective repair of TOF in a single center,
specifically to identify risk factors associated with
postoperative complications and LOS.MATERIALS AND METHODS
Study Design
This was a retrospective cohort study focusing on early surgical results
in young infants. Patients with TOF were selected if elective complete sur-
gical repair occurred between January 1, 1995, and January 31, 2009, at
6 months of age or younger. Elective repair was defined as a routinely
scheduled surgical procedure in a hemodynamically stable patient without
cyanosis requiring therapy. Patients were referred for surgical repair by
their cardiologist in consultation with the multidisciplinary care team at
our institution. Exclusion criteria were as follows: (1) age older than
6 months, (2) experiencing a hypercyanotic episode requiring intervention;
(3) requiring alprostadil, mechanical ventilatory support, morphine, and/or
phenylephrine; (4) undergoing prior cardiac surgery or interventional pal-
liation; and (5) having additional major cardiac defects (eg, complete atrio-
ventricular septal defect). In addition, to ensure that our population
included patients cared for in a home environment before surgery, we
excluded any patient not discharged from the hospital before the TOF re-
pair. Medical records were reviewed for patient demographics, associated
cardiovascular anomalies, documented genetic abnormalities, reports
of cardiac catheterization, and presence of cyanosis requiring therapy.rdiovascular Surgery c Volume 147, Number 2 713
TABLE 1. Summary of demographic, clinical, surgical, and outcome
characteristics of the study cohort (n ¼ 277)
Demographic and clinical variables
Male 158 (57%)
Age at surgery (d) 104 (20-209)
Weight at surgery (kg) 5.4 (2.4-9.6)
22q11 microdeletion 19 (7.2%)
Trisomy 21 18 (6.6%)
Any chromosomal abnormality 44 (16.7%)
History of prematurity (<38 wk gestation) 23 (8.3%)
RAAwith mirror image branching 65 (23.5%)
RAAwith aberrant left subclavian artery 14 (5.1%)
LAAwith aberrant right subclavian artery 3 (1.1%)
Left SVC to coronary sinus 21 (7.6%)
Additional VSD 19 (6.9%)
Surgical variables
Use of DHCA 64 (23.1%)
DHCA time (n ¼ 64) (min) 34 (10-61)
ACC time (min) 35 (14-111)
CPB time (min) 63 (18-201)
TST (DHCA þ CPB) (min) 66 (18-201)
More than 1 bypass run 14 (5.1%)
Approach to close ventricular septal defect
Atrial 194 (70.3%)
Ventricular 70 (25.4%)
Combined 12 (4.4%)
Use of transannular patch 187 (67.5%)
Right ventricular muscle bundle resection 210 (75.8%)
Residual atrial communication 230 (83.6%)
Postoperative course
Length of intensive care unit stay (d) 3 (1-82)
Length of total hospital stay (d) 5 (2-118)
Length of stay,>7 d 35 (12.6%)
Complication* 32 (11.6%)
CPR 6 (2.2%)
ECMO 3 (1.1%)
Reoperation for bleeding 10 (3.6%)
Reoperation for residual lesion 3 (1.1%)
Reoperation for pacemaker 1 (0.4%)
Catheterization (diagnostic) 3 (1.1%)
Catheterization (interventional) 1 (0.4%)
Pleural/pericardial drain placement 8 (2.9%)
Re-intubation 7 (2.5%)
Tracheostomy 3 (1.1%)
Stroke 2 (0.7%)
Data are presented as median (range) or count (% of total). CPR, Cardiopulmonary
resuscitation; ECMO, extracorporeal membrane oxygenator; LAA, left aortic arch;
SVC, superior vena cava; RAA, left aortic arch; DHCA, deep hypothermic circulatory
arrest; ACC, aortic cross-clamp; CPB, cardiopulmonary bypass; TST, total support
time; VSD, ventricular septal defect. *48 total complications occurred in 32 patients.
Abbreviations and Acronyms
ACC ¼ aortic cross-clamp
CPB ¼ cardiopulmonary bypass
DHCA ¼ deep hypothermic circulatory arrest
LOS ¼ length of stay
LSCA ¼ left subclavian artery
RAA ¼ right aortic arch
TOF ¼ tetralogy of Fallot
TST ¼ total support time
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DSurgical notes were reviewed for descriptions of repair technique, addi-
tional surgical procedures, and duration of intraoperative support (cardio-
pulmonary bypass [CPB], aortic cross-clamp [ACC], and deep
hypothermic circulatory arrest [DHCA]). The perioperative course was re-
viewed for length of intensive care unit and hospital stay, early reoperation
(within 30 days of surgery or before hospital discharge), and incidence of
major organ dysfunction or complications.
Complications were defined as atypical clinical events requiring initia-
tion of unanticipated medical or interventional procedures. Given pub-
lished reports of prolonged hospital stay, longer intensive care unit stay,
and longer duration of inotropic and ventilator support in patients younger
than 3 months,4,9,19,20,24 we analyzed the cohort using this age cut-off value
as a divider. Patients were analyzed in a subgroup of those younger than
3 months age, which included all patients 11.99 weeks and younger
(patients 3 months were 12 weeks). The Institutional Review Board
at The Children’s Hospital of Philadelphia approved the study, and in-
formed consent was waived.
Statistical Methods
Standard descriptive statistics were used to summarize the data and
were expressed as mean standard deviation for normally distributed con-
tinuous variables, as median with range for skewed continuous variables,
and as count with a percentage of the total for categoric variables. Differ-
ences in covariates based on age at surgery (<3 vs 3 months) were tested
using the Student t test, theWilcoxon rank sum test, or the chi-square test as
appropriate. Measures of association between potential risk factors and
outcomes of interest were assessed using logistic regression for dichoto-
mous outcome variables (complications), and linear regression for contin-
uous outcome variables (natural log-transformed length of hospital stay).
Covariates with a P value less than .2 in univariate testing were considered
for inclusion in a multivariable model and were retained in the final model
if the P value was less than .05 or if there was evidence for significant
confounding or effect modification. Statistical significance was established
at a 2-tailed P value less than .05. All statistical analyses were performed
using STATA version 10 (Stata Corp, College Station, Tex).
RESULTS
Preoperative Data
Between January 1, 1995, and January 31, 2009, there
were 603 patients with TOF who were admitted for surgical
repair, of whom 277 met inclusion criteria and constituted
our study cohort. Demographic, anatomic, clinical, surgi-
cal, and outcome characteristics of the cohort are summa-
rized in Table 1. The median age at repair was 104 days
(3.46months) and 110 patients were younger than 3months.
At the time of chart review, 44 patients (16.7%) were noted
to have chromosomal abnormalities. Thirteen patients (5%)714 The Journal of Thoracic and Cardiovascular Surghad either no record of chromosomal abnormality, or an un-
known chromosomal anomaly.
Surgical Data
Surgical interventions are summarized in Table 1. A
transannular patch was used in the majority (187; 67.5%)
of patients. There was a trend toward greater use ofery c February 2014
TABLE 2. Variables significantly associated with postoperative complications (by logistic regression)
Covariate
Complication Univariate Multivariate
Yes (n ¼ 32) No (n ¼ 245) OR (95% CI) P OR (95% CI) P
Weight at surgery (kg) 4.95 (2.9-7.5) 5.5 (2.4-9.6) 0.69 (0.5-0.97) .034
Use of DHCA 14 (43.8%) 50 (20.4%) 3 (1.4-6.5) .004
DHCA (min) 42.5 (26-61) 32 (10-60) 1.13 (1.04-1.22) .003
ACC (min) 45.5 (16-93) 34 (14-111) 1.03 (1.01-1.05) .002
CPB (min) 81.5 (26-138) 58 (18-201) 1.03 (1.01-1.04) <.001
Total support time (min) 93 (26-199) 61 (18-201) 1.02 (1.01-1.03) <.001 1.02 (1.01-1.04) <.001
RAAwith aberrant LSCA 4 (12.5%) 10 (4.1%) 3.4 (1-11.4) .05 4.8 (1.3-18) .02
Left SVC to coronary sinus 6 (18.8%) 15 (6.1%) 3.5 (1.3-9.9) .016
Data are presented as median (range) or count (percentage of total).CI, Confidence interval;OR, odds ratio; SVC, superior vena cava;DHCA, deep hypothermic circulatory arrest;
ACC, aortic cross-clamp; CPB, cardiopulmonary bypass; RAA, left aortic arch; LSCA, left subclavian artery.
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Dtransatrial ventricular septal defect closure over time. An
inter-atrial communication was created or maintained in
230 patients (83%), and was closed or not created in 45 pa-
tients (16.2%). Data regarding the status of the atrial sep-
tum were missing in 2 patients.
For the purposes of this study, total support time (TST)
was the sum of time spent on CPB plus DHCA (if used).
Thus, if no DHCA was used, CPB time equaled TST.
DHCAwas used in 64 patients (23.1%) with a median du-
ration of 34 minutes, and use declined dramatically after
the first year of the study (14 of 15; 93.3%) to the last year
of the study (2 of 24; 8.3%). DHCA was used at the
surgeon’s discretion and exact criteria were not available
for review. Median ACC and TST times were 35 and
66 minutes, respectively, over 14 years. There was a pro-
gressive decrease in median TST from 102 minutes in
1995 to 38 minutes in 2008. The annual surgical volume
increased over the same time period.
Mortality
The hospital mortality rate in this cohort was zero.
Morbidity
Hospital and intensive care unit LOS for the cohort are
summarized in Table 1. The median duration of hospitaliza-
tion in the intensive care unit was 3 days (range, 1-82 days),
with an overall trend toward a shorter hospital stay over the
duration of the series. The majority of patients (242;
87.4%) were discharged homewithin 7 days of elective sur-
gical repair (Table 1); 21.6% (60 patients) were discharged
on or before the third postoperative day.
Although the postoperative course was uncomplicated
in 245 patients (88.4%), a wide range of complications
occurred (Table 1). Six patients required cardiopulmonary
resuscitation, 3 of whom had a return of spontaneous cir-
culation, and 3 patients were rescued with extracorporeal
membrane oxygenation support. Ten patients (3.6%)
required reoperation for bleeding, and 3 patients required
reoperation for residual lesions. In total, 4 patients
(1.4%) required reoperation (3 for residual defects, 1 forThe Journal of Thoracic and Caa permanent pacemaker), and 1 patient required re-
intervention (0.3%) with the placement of a left pulmonary
artery stent before discharge. In total, 48 complications
occurred in 32 patients. There was no surgeon effect found
that remained significant after TST was controlled for,
although the majority of surgeries (159) were performed
by a single surgeon.
Table 2 summarizes the potential risk factors associated
with postoperative complications. In univariate analysis,
lower weight at surgery, longer surgical support times,
the use of DHCA, a right aortic arch (RAA) with an aberrant
left subclavian artery (LSCA), and a left superior vena cava
to coronary sinus were associated with increased odds
of measured complications. However, with multivariate
analysis, only TST (P< .001) and RAA with an aberrant
LSCA (P¼ .02) were associated independently with higher
complication rates. Risk factors for hospital LOS (Table 3)
by univariate analysis showed an association with weight at
surgery, use of DHCA, lengths of DHCA, ACC, CPB, and
TST, as well as RAAwith aberrant LSCA. With multivari-
ate analysis, longer TSTs (P<.001), younger age at surgery
(P < .001), presence of a chromosomal abnormality
(P< .001), and presence of a postoperative complication
(P<.001) were associated independently with longer LOS.
Patients younger than 3 months of age had a 1-day longer
median hospital stay that reached statistical significance
(5 vs 4 days; P< .001). There was also an 11-minute in-
crease in TST in the group that was younger than 3 months
(77.3 35.1 min vs 66.4 34 min; P<.01). A transannular
patch was used more frequently in those younger than
3 months (89 patients [80.9%] vs 98 patients [58.7%];
P<.001). The incidence of complications was not statisti-
cally significantly higher in the those younger than 3months
(15.5%) versus those 3 months or older (9%) (P ¼ .1).
DISCUSSION
In this retrospective review spanning 14 years, elective
repair in infancy resulted in no mortality, a hospital LOS
less than 1 week in 87.4% of patients, and an 11.6% com-
plication rate. Not unexpectedly, the presence ofrdiovascular Surgery c Volume 147, Number 2 715
TABLE 3. Variables significantly associated with hospital LOS (by linear regression, using natural log-transformed LOS)
Covariate
Univariate Multivariate
Coefficient (95% CI) P Coefficient (95% CI) P
Age at surgery (mo) 0.1 (0.15 to 0.05) <.001 0.07 (0.1 to 0.04) <.001
Weight at surgery (kg) 0.12 (0.17 to 0.06) <.001
Chromosomal abnormality 0.42 (0.24-0.6) <.001 0.31 (0.18-0.44) <.001
Use of DHCA 0.38 (0.22-0.53) <.001
DHCA (min) 0.02 (0.006-0.04) .008
ACC (min) 0.01 (0.009-0.02) <.001
CPB (min) 0.01 (0.008-0.013) <.001
TST (min) 0.008 (0.006-0.01) <.001 0.005 (0.003-0.006) <.001
Left SVC to coronary sinus 0.4 (0.15-0.65) .002
VSD closed through ventricle 0.26 (0.11-0.4) .001
Postoperative complication 1.07 (0.9-1.2) <.001 0.92 (0.76-1.1) <.001
CI, Confidence interval; SVC, superior vena cava; VSD, ventricular septal defect; DHCA, deep hypothermic circulatory arrest; ACC, aortic cross-clamp; CPB, cardiopulmonary
bypass; TST, total support time.
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Da postoperative complication increased hospital LOS. In ad-
dition, TST, younger age at surgery, and the presence of
a chromosomal abnormality increased hospital LOS.
The rate of early reoperation for hemodynamically sig-
nificant residual lesions in our series of 1.4% (4 of 277)
was similar to that reported elsewhere.4-6,8,11,15-17,19,24
Although an association was found between RAA with
aberrant LSCA and increased complications, we could pos-
tulate no cause of this association in a retrospective review.
These patients did not have a higher incidence of the 22q11
deletion. Longer TST also was associated with increased
complications. We did not show any increase in postopera-
tive complications in the younger (<3 months) age group
when compared with the 3 month and older group as a sub-
set, although by logistic regression we noted that younger
age was associated with a median 1-day longer hospital
stay. Also, the presence of genetic anomalies was associated
with a longer hospital stay. This was also found in other
studies.25 Overall, our patients had a relatively short LOS,
and 242 patients (87.4%) were discharged by 7 days after
surgery in this series.
Limitations of our study were similar to those of other
retrospective reviews. Results from our single center
may not be generalizable and review of the medical re-
cords left some questions about our patients unanswered.
Specifically, we were not able to accurately obtain an
incidence of postoperative arrhythmias, and we did not
have sufficient data to extend our study to important
longer-term outcomes. Although longer-term physiologic
and quality-of-life outcomes are exceedingly important
to assess this approach, these findings were beyond the
scope of this study and will be the subject of future
investigations.
We advocate repair of asymptomatic infants with TOF in
early infancy. Waiting beyond the neonatal period allows
for a decrease in pulmonary vascular resistance and matura-
tion of other organ systems (eg, the kidney), which may im-
prove the postoperative course after CPB, and may be better716 The Journal of Thoracic and Cardiovascular Surgtolerated by the central nervous system. However, an exces-
sive delay in repair may result in prolonged hypoxemia, the
risk of sudden hypercyanotic spells, as well as significant
right ventricular hypertrophy that may complicate the surgi-
cal exposure and lead to diastolic dysfunction that compli-
cates the postoperative course. Because of the expected
right ventricular dysfunction at any age, an additional man-
agement strategy used in the great majority of cases was the
intentional use of a limited interatrial communication. We
believe this feature allows for left atrial filling and mainte-
nance of left ventricular output at times in the postoperative
course when right heart dysfunction is limiting effective
pulmonary blood flow. However, the benefits of an early
postoperative pretricuspid shunt must be weighed against
the concerns of potential residual atrial defects over time.
Our results support the hypothesis that elective repair of
TOF can be performed in early infancy with low morbidity,
a short hospital stay, and a low mortality rate (none in this
series) in the great majority of patients. We suggest elective
repair is performed acceptably in early infancy, and data ob-
tained in this retrospective review suggest that elective re-
pair at age 3 to 6 months is associated with improved
outcome for patients who are asymptomatic.
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